Laboratory detection of artemisinin-resistant plasmodium falciparum

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 6, 2014, Pages 3157-3161

  Chotivanich, Kesinee ^a,b   Tripura, Rupam ^b   Das, Debashish ^b   Yi, Poravuth ^c   Day, Nicholas P J ^b,d   Pukrittayakamee, Sasithon ^a,b   Chuor, Char Meng ^c   Socheat, Duong ^c   Dondorp, Arjen M ^b,d   White, Nicholas J ^b,d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^c National Center for Parasitology Entomology and Malaria Control   (Cambodia)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; ARTESUNATE; MEFLOQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; EX VIVO STUDY; GENETIC PREDISPOSITION; HALF LIFE TIME; HUMAN; HUMAN TISSUE; IC 50; MALARIA FALCIPARUM; MICROORGANISM DETECTION; NONHUMAN; PARASITE CLEARANCE; PARASITE DEVELOPMENT; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SCHIZONT; TROPHOZOITE; VENOUS BLOOD; ANIMAL; BLOOD; DRUG EFFECTS; DRUG RESISTANCE; DRUG SENSITIVITY; GROWTH, DEVELOPMENT AND AGING; PARASITOLOGY; PHENOTYPE;

ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE; HALF-LIFE; MALARIA, FALCIPARUM; PARASITIC SENSITIVITY TESTS; PHENOTYPE; PLASMODIUM FALCIPARUM;

EID: 84901283343     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01924-13     Document Type: Article

References (27)

1. World Health Organization. 2010. Guidelines for the treatment of malaria, 2nd ed, p 13-47. WC 770. World Health Organization Press, Geneva, Switzerland.
2. Hien TT, White NJ. 1993. Qinghaosu. Lancet 341:603-608. http://dx.doi.org/10.1016/0140-6736(93)90362-K.
3. White NJ. 2008. Qinghaosu (artemisinin): the price of success. Science 320:330-334. http://dx.doi.org/10.1126/science.1155165.
4. Ashley EA, White NJ. 2005. Artemisinin-based combinations. Curr. Opin. Infect. Dis. 18:531-536. http://dx.doi.org/10.1097/01.qco.0000186848.46417.6c.
5. White NJ. 2008. The role of anti-malarial drugs in eliminating malaria. Malar. J. 7(Suppl 1):S8. http://dx.doi.org/10.1186/1475-2875-7-S1-S8.
6. Barnes KI, White NJ. 2005. Population biology and antimalarial resistance: the transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Trop. 94:230-240. http://dx.doi.org/10.1016/j.actatropica.2005. 04.014.
7. Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans Gesase JS, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba Karema MC, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WB, Tshefu Onyamboko AKMA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NP, White NJ; AQUAMAT group. 2010. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 376: 1647-1657. http://dx.doi.org/10.1016/S0140-6736(10)61924-1.
8. World Health Organization. 2011. World malaria report 2011. World Health Organization, Geneva, Switzerland. http://www.who.int/malaria/world-malaria- report-2011/en.
9. Alker AP, Lim P, Sem R, Shah NK, Yi P, Bouth DM, Tsuyuoka R, Maguire JD, Fandeur T, Ariey F, Wongsrichanalai C, Meshnick SR. 2007. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am. J. Trop. Med. Hyg. 76:641-647.
10. Denis MB, Tsuyuoka R, Lim P, Lindegardh N, Yi PTop Socheat SND, Fandeur T, Annerberg A, Christophel EM, Ringwald P. 2006. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Trop. Med. Int. Health 11:1800-1807. http://dx.doi.org/10. 1111/j.1365-3156.2006.01739.x.
11. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM; Artemisinin resistance in Cambodia 1 (ARC1) Study Consortium. 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 359:2619-2620. http://dx.doi.org/10.1056/NEJMc0805011.
12. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ. 2009. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361:455-467. http://dx.doi.org/10.1056/NEJMoa0808859.
13. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F. 2012. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 379:1960-1966. http://dx.doi.org/10.1016/S0140-6736(12)60484-X.
14. Carrara VI, Zwang J, Ashley EA, Price RN, Stepniewska K, Barends M, Brockman Anderson AT, McGready R, Phaiphun L, Proux S, van Vugt M, Hutagalung R, Lwin Phyo KMAP, Preechapornkul P, Imwong M, Pukrittayakamee S, Singhasivanon P, White NJ, Nosten F. 2009. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoSOne4:e4551. http://dx.doi.org/10.1371/journal.pone. 0004551.
15. Saralamba S, Pan-Ngum W, Maude RJ, Lee SJ, Tarning J, Lindegårdh N, Chotivanich K, Nosten F, Day NP, Socheat D, White NJ, Dondorp AM, White LJ. 2011. Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A. 108:397-402. http://dx.doi.org/10.1073/pnas. 1006113108.
16. Das D, Tripura R, Phyo AP, Lwin KM, Tarning J, Lee SJ, Hanpithakpong W, Stepniewska K, Menard D, Ringwald P, Silamut K, Imwong M, Chotivanich K, Yi P, Day NP, Lindegardh N, Socheat D, Nguon C, White NJ, Nosten F, Dondorp AM.2013. Effect of high-dose or split-dose artesunateonparasite clearance in artemisinin-resistant falciparum malaria. Clin. Infect. Dis. 56:e48-e58. http://dx.doi.org/10.1093/cid/cis958.
17. Silamut K, White NJ. 1993. Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 87:436-443. http://dx.doi.org/10.1016/0035-9203(93)90028-O.
18. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, Thaithong S, Brown KN. 1993. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol. Biochem. Parasitol. 61:315-320. http://dx.doi.org/10.1016/0166-6851(93)90077-B.
19. Flegg JA, Guerin PJ, White NJ, Stepniewska K. 2011. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar. J. 10:339. http://dx.doi.org/10.1186/1475-2875-10-339.
20. Webster HK, Boudreau EF, Pavanand K, Yongvanitchit K, Pang LW. 1985. Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method. Am. J. Trop. Med. Hyg. 34:228-235.
21. Bacon DJ, Latour C, Lucas C, Colina O, Ringwald P, Picot S. 2007. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates. Antimicrob. Agents Chemother. 51:1172-1178. http://dx.doi.org/10.1128/AAC.01313-06.
22. Noedl H, Attlmayr B, Wernsdorfer WH, Kollaritsch H, Miller RS. 2004. A histidine-rich protein 2-based malaria drug sensitivity assay for field use. Am. J. Trop. Med. Hyg. 71:711-714.
23. Druilhe P, Moreno A, Blanc C, Brasseur PH, Jacquier P. 2001. A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigencapture enzyme-linked immunosorbent assay. Am. J. Trop. Med. Hyg. 64:233-241.
24. Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeung N, Chy S, Duong S, Leang R, Ringwald P, Dondorp AM, Tripura R, Benoit-Vical F, Berry A, Gorgette O, Ariey F, Barale JC, Mercereau-Puijalon O, Menard D. 2013. Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob. Agents Chemother. 57:914-923. http://dx.doi.org/10.1128/AAC.01868- 12.
25. Klonis N, Xie SC, McCaw JM, Crespo-Ortiz MP, Zaloumis SG, Simpson JA, Tilley L. 2013. Altered temporal response of malaria parasites determines differential sensitivity to artemisinin. Proc. Natl. Acad. Sci. U. S. A. 26:5157-5162. http://dx.doi.org/10.1073/pnas.1217452110.
26. Tucker MS, Mutka T, Sparks K, Patel J, Kyle DE. 2012. Phenotypic and genotypic analysis of in vitro-selected artemisinin-resistant progeny of Plasmodium falciparum. Antimicrob. Agents Chemother. 56:302-314. http://dx.doi.org/10.1128/AAC.05540-11.
27. Anderson TJ, Nair S, Nkhoma S, Williams JT, Imwong M, Yi P, Socheat D, Das D, Chotivanich K, Day NP, White NJ, Dondorp AM. 2010. High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J. Infect. Dis. 201:1326-1330. http://dx.doi.org/10.1086/651562.